ノースカロライナにおける食道腺癌の臨床試験
ノースカロライナ内の拠点で、食道腺癌に関する12件の研究が参加者を募集しています。
ノースカロライナ内の都市
公式研究テキスト（英語）
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
- Cone Health MedCenter Asheboro, Asheboro
- Cone Health Cancer Center at Alamance Regional, Burlington
- Southeastern Medical Oncology Center-Clinton, Clinton
- 他6件
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/10/05更新 · NCT06203600mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
- Southeastern Medical Oncology Center-Clinton, Clinton
- Southeastern Medical Oncology Center-Goldsboro, Goldsboro
- 他5件
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT05677490A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
- University of North Carolina Medical Center, Chapel Hill
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07221149Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Localized Esophageal Adenocarcinoma
- Duke University Medical Center, Durham
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07603375Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms
- University of North Carolina at Chapel Hill, Chapel Hill
被験者募集中健康なボランティア歓迎
50歳以上 · 全性別 · 2026/09/15更新 · NCT06687603Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/14更新 · NCT06732388Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
- University of North Carolina School of Medicine, Chapel Hill
被験者募集中
18歳〜89歳 · 全性別 · 2026/09/11更新 · NCT05753748Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- Research Site, Charlotte
- Research Site, Wilmington
- Research Site, Winston-Salem
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/09更新 · NCT07431281Obeticholic Acid for Prevention in Barrett's Esophagus
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/11更新 · NCT04939051Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
- University of North Carolina at Chapel Hill, Chapel Hill
被験者募集中
18歳〜89歳 · 全性別 · 2026/07/01更新 · NCT05530343First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
- Research Site, Durham
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/12更新 · NCT07284186A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer
- Durham VA Medical Center, Durham, NC, Durham
被験者募集中第2相
18歳以上 · 全性別 · 2025/11/05更新 · NCT05563766ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。